Industry Background:
Cannabidiol (CBD) is one of the hundreds of cannabinoids that are found in the cannabis plant. This is a naturally occurring substance, can be extracted & mixed with a carrier oil, often hemp seed or coconut, to create CBD oil. Cannabidiol oil can be derived from two different species of cannabinoids such as marijuana and hemp. Rising awareness about the health benefits of Cannabidiol is the major factors that are expected to drive the growth of the global Cannabidiol market. The demand for Cannabidiol is increasing around the globe owing to their capacity to cure various ailments in the human body. Cannabidiol in the form of CBD oil is used for the protection from Alzheimer's disease and has anti-inflammatory properties. It also benefits in the treatment of epilepsy and mental health disorders. The adoption rate of Cannabidiol is increasing because they help in drug withdrawal. It is highly recommended, as it can suppress the growth of cancer cells to prevent cancer.This growth is primarily driven by Growing Awareness Regarding Health benefits of CBD oil and Globally Increasing Millennial Population and Rising E-Commerce Industry.
Globally, a noticeable market trend is evident Increasing Legalization of Cannabis-Based Products
. Major Players, such as ENDOCA BV (Netherlands), CBD American Shaman (United States), Isodiol International Inc. (Canada), Medical Marijuana Inc. (United States), Aurora Cannabis Inc. (Canada), Cannoid LLC (United States), Canopy Growth Corporation (Canada), CV Sciences, Inc. (United States), Elixinol LLC (United States) and NuLeaf Naturals, LLC. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
March 4, 2019: Aurora Completes Whistler Medical Acquisition. The Transaction provides Aurora with a premium and differentiated organic certified product suite, expanding both its medical and consumer offerings, and reinforcing Aurora's presence in the well-established west coast cannabis market.
On 21 Jan. 2019, Canopy Growth Corporation has announced the expansion of its business in the European regions such as the United Kingdom and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production as well as distribution network serving the needs of physicians and their patients throughout the continent.
Regulatory Insights:
In the United States, Food and Drug Administration approved the CBD drug Epidiolex for treatment of two epilepsy disorders. Also, The U.S. Drug Enforcement Administration (DEA) has assigned Epidiolex a Schedule V classification as well as non-Epidiolex CBD remains a Schedule I drug prohibited for any usage. In 2018, the World Health Organization recommended that CBD remain unscheduled. CBD is not scheduled under any United Nations drug control treaties.
Market Drivers
- Growing Awareness Regarding Health benefits of CBD oil
- Globally Increasing Millennial Population and Rising E-Commerce Industry
Market Trend
- Increasing Legalization of Cannabis-Based Products
- Legalization of Cannabis for Medicinal and Recreational Activities
Restraints
- High Cost of the Product
- Availability of Low Yield
Opportunities
Emerging Markets and The advent of advanced cultivation processes and Growing Investments made for the Production of Cannabis Oil
Challenges
Lack of Harvesting Innovations and Processing Facilities and Strict Government Regulations in Some Countries
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Cannabidiol Study Sheds Light on
The Cannabidiol Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Cannabidiol industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Cannabidiol industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.